160 related articles for article (PubMed ID: 8620966)
1. Peak inspiratory flow through Turbuhaler in acute asthma.
Brown PH; Ning AC; Greening AP; McLean A; Crompton GK
Eur Respir J; 1995 Nov; 8(11):1940-1. PubMed ID: 8620966
[TBL] [Abstract][Full Text] [Related]
2. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler).
Engel T; Heinig JH; Madsen F; Nikander K
Eur Respir J; 1990 Oct; 3(9):1037-41. PubMed ID: 2289551
[TBL] [Abstract][Full Text] [Related]
3. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
Zhang QL; Zheng JP; Pan WH; He H; Chen GL; An JY; Yuan LF; Luo DF
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
[TBL] [Abstract][Full Text] [Related]
4. Peak inspiratory flow through Turbuhaler in chronic obstructive airways disease.
Dewar MH; Jamieson A; McLean A; Crompton GK
Respir Med; 1999 May; 93(5):342-4. PubMed ID: 10464901
[TBL] [Abstract][Full Text] [Related]
5. Can patients achieve sufficient peak inspiratory flow rate (PIFR) with Turbuhaler® during acute exacerbation of asthma?
Mohd Rhazi NA; Muneswarao J; Abdul Aziz F; Ibrahim B; Kamalludin A; Soelar SA
J Asthma; 2023 Aug; 60(8):1608-1612. PubMed ID: 36650693
[TBL] [Abstract][Full Text] [Related]
6. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations].
Grabowski M; Barg W; Chmielowicz B; Kopeć A; Panaszek B
Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981
[TBL] [Abstract][Full Text] [Related]
7. [Peak inspiratory flow using 2 different inhalers and a new portable device].
García-Marcos Alvarez L; Martínez Torres A; Guillén Pérez JJ; Martínez Victoria A
An Esp Pediatr; 2001 Feb; 54(2):110-3. PubMed ID: 11181205
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma.
Nana A; Youngchaiyud P; Maranetra N; Boe J; Löfdahl CG; Selroos O; Ståhl E
Respir Med; 1998 Feb; 92(2):167-72. PubMed ID: 9616507
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma.
Virchow JC; Rodriguez-Roisin R; Papi A; Shah TP; Gopalan G
BMC Pulm Med; 2016 Mar; 16():42. PubMed ID: 26987997
[TBL] [Abstract][Full Text] [Related]
10. [The efficacy of Turbuhaler dry powder inhaler in Japanese asthma--measurement of peak inspiratory flow when using Turbuhaler].
Kaneko N; Narushima M; Tanaka K; Suzuki H
Arerugi; 1996 Jul; 45(7):649-54. PubMed ID: 8831169
[TBL] [Abstract][Full Text] [Related]
11. The inhalation characteristics of patients when they use different dry powder inhalers.
Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
[TBL] [Abstract][Full Text] [Related]
12. Peak inspiratory flow through diskus and turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL).
van der Palen J
Respir Med; 2003 Mar; 97(3):285-9. PubMed ID: 12645837
[TBL] [Abstract][Full Text] [Related]
13. Influence of inspiratory capacity on bronchodilatation via Turbuhaler or pressurized metered-dose inhaler in asthmatic children: a comparison.
Hirsch T; Peter-Kern M; Koch R; Leupold W
Respir Med; 1997 Jul; 91(6):341-6. PubMed ID: 9282236
[TBL] [Abstract][Full Text] [Related]
14. Peak inspiratory flow rates generated through the Novolizer and the Turbuhaler dry powder inhaler devices by children with stable asthma.
von Berg A; Kremer HJ; Ellers-Lenz B; Conrad F; Erb K; Maus J; Hermann R
J Aerosol Med; 2007; 20(1):50-8. PubMed ID: 17388753
[TBL] [Abstract][Full Text] [Related]
15. Measurement of inspiratory flow in children with acute asthma.
Bentur L; Mansour Y; Hamzani Y; Beck R; Elias N; Amirav I
Pediatr Pulmonol; 2004 Oct; 38(4):304-7. PubMed ID: 15334507
[TBL] [Abstract][Full Text] [Related]
16. Variation of peak inspiratory flow through dry powder inhalers in children with stable and unstable asthma.
Kamps AW; Brand PL; Roorda RJ
Pediatr Pulmonol; 2004 Jan; 37(1):65-70. PubMed ID: 14679492
[TBL] [Abstract][Full Text] [Related]
17. Peak inspiratory flow rate after methacholine challenge in asthmatic patients and its impact on the effect of formoterol via different inhalers.
Haidl P; Schmidt F; Wiese C; Koehler D
J Aerosol Med; 2006; 19(3):364-71. PubMed ID: 17034311
[TBL] [Abstract][Full Text] [Related]
18. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.
Broeders ME; Molema J; Hop WC; Folgering HT
J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907
[TBL] [Abstract][Full Text] [Related]
19. Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizer.
Nielsen KG; Skov M; Klug B; Ifversen M; Bisgaard H
Eur Respir J; 1997 Sep; 10(9):2105-9. PubMed ID: 9311511
[TBL] [Abstract][Full Text] [Related]
20. Reduced Peak Inspiratory Effort through the Diskus((R)) and the Turbuhaler((R)) due to Mishandling is Common in Clinical Practice.
Melani AS; Bracci LS; Rossi M
Clin Drug Investig; 2005; 25(8):543-9. PubMed ID: 17532698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
